Santen Pharmaceutical Co Employees 2024

Santen Pharmaceutical Co has 4,108 undefined employees this year.

Compared to the previous year, Santen Pharmaceutical Co had 0% more employees.

The number of employees has a direct impact on the efficiency and productivity of Santen Pharmaceutical Co. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

The number of employees can also have an impact on investors of Santen Pharmaceutical Co, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

An increase in equity of Santen Pharmaceutical Co can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

A reduction in equity of Santen Pharmaceutical Co can impair its financial stability and decrease its ability to fulfill future investments and obligations.

Some factors that can influence the equity of Santen Pharmaceutical Co include, among others, revenue development, profit and loss statement, dividend payments, and investments.

The equity of Santen Pharmaceutical Co is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

The number of employees at Santen Pharmaceutical Co can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

In recent years, the number of employees at Santen Pharmaceutical Co has changed by 0.

Santen Pharmaceutical Co currently has 4,108 undefined employees.

The number of employees is important for investors of Santen Pharmaceutical Co as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

To change the number of employees, Santen Pharmaceutical Co can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

Over the past 12 months, Santen Pharmaceutical Co paid a dividend of 34 JPY . This corresponds to a dividend yield of about 1.88 %. For the coming 12 months, Santen Pharmaceutical Co is expected to pay a dividend of 34.87 JPY.

The current dividend yield of Santen Pharmaceutical Co is 1.88 %.

Santen Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

Santen Pharmaceutical Co paid dividends every year for the past 23 years.

For the upcoming 12 months, dividends amounting to 34.87 JPY are expected. This corresponds to a dividend yield of 1.93 %.

Santen Pharmaceutical Co is assigned to the 'Health' sector.

To receive the latest dividend of Santen Pharmaceutical Co from 12/1/2024 amounting to 17 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

The last dividend was paid out on 12/1/2024.

In the year 2023, Santen Pharmaceutical Co distributed 32 JPY as dividends.

The dividends of Santen Pharmaceutical Co are distributed in JPY.